- No hidden fees
Avg weight loss clinic
- No hidden fees
If you seek to lose weight and improve your health, you may wonder about the different obesity medications available. Wegovy is an obesity medication manufactured by Novo Nordisk that has been on the market for some 15 years and has indicated its effectiveness in helping people lose weight. Ozempic, a lower-dose injection version of Semaglutide, is also a standard weight loss drug.
The main difference between Wegovy and Ozempic is the dosage of Semaglutide. Wegovy has a higher dosage, which makes it more effective at crossing the blood-brain barrier. This barrier regulates the entry of microorganisms into the central nervous system, so Wegovy's higher dosage makes it a more effective treatment for weight loss.
OzempicTM and RybelsusTM are available only through a prescription from a healthcare professional. These drugs should be combined with a balanced diet and increased physical activity to help adults manage their weight-related health problems.
Wegovy is excellent for chronic weight management and reducing the negative impacts of obesity and associated comorbidities. Wegovy can reduce the risk of heart disease, stroke, heart attack, and other weight related ailments.
WEGOVY produces the same effects in the body as incretins. Incretins are hormones released when you eat and tell the brain, endocrine, and digestive system that food has been consumed. This flood of hormones and neurotransmitters communicates feelings of fullness, which can help people lose weight. By injecting WEGOVY protein weekly, blood sugar levels can be lowered; therefore, weight loss is supported. In addition, WEGOVY increases the feeling of fullness after meals, reducing overeating and cravings.
While Wegovy is not a miracle cure, combined with a healthy lifestyle, it can be an extremely effective tool for weight loss. Our Calibrate program has evidence-based lifestyle recommendations to help those taking Wegovy get the most out of this medication and maximise their weight loss results.
Wegovy is part of the GLP-1 agonist receptors class, and its main active ingredient is a popular weight loss drug called Semaglutide. WEGOVY helps people lose weight by binding to the GLP-1 receptor in the brain, muscles, stomach, liver, and pancreas. This imitates your body's natural response to GLP-1, which may be lower in obese individuals.
The Wegovy® pen utilises an ultra-fine needle, and an injection is typically painless. Our doctor will provide instructions on how to easily and quickly self-inject the pen.
Wegovy should be administered weekly, on the same day each week, with or without meals. Subcutaneously inject into the abdomen, thigh, or upper arm. The starting dose should be 0.25 mg once weekly for four weeks. At 4-week intervals, the dose should be increased to 2.4 mg. Monitor blood sugar levels before and during treatment with Wegovy to ensure safe and effective treatment.
When you join Weight Loss Coach, you will work closely with a licensed physician who will determine the best dosage for you as an individual. It cannot be taken as a pill, so it must be injected. The Wegovy® pen utilises an ultra-fine needle, and an injection is typically painless. Our doctor will provide instructions on how to easily and quickly self-inject the pen.
As with any medication, Wegovy may have side effects. In case of severe side effects such as anaphylaxis or shortness of breath, seek immediate medical attention. Wegovy is commonly associated with:
The GLP-1 category includes multiple weight-loss drugs, including Mounjaro (tirzepatide). Among the other medications that contain GLP-1 are: